NEDNA
Live / Applied — Statement of use — non-final action mailed (as of 13 Feb 2026)
What this means for you
Not registered yet, but its 09 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97927503
- Mark type
- Stylized text
- Filed
- 09 May 2023
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Kristen Mollnow Walsh
Goods and services
- Class 005 — Pharmaceuticals: DNA extracts, namely, nucleic acid sequences for medical use; Therapeutic DNA, namely, nucleic acid sequences for medical and veterinary purposes; Biological preparations, namely, rAAV vectors and DNA extracts for production of DNA vectors and viral vectors for medical purposes
Owner
- Asklepios BioPharmaceutical, Inc., Research Triangle Park, NC, US
- Asklepios BioPharmaceutical, Inc., Research Triangle Park, NC, US
Prosecution history
- 13 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Feb 2026 — NON-FINAL ACTION E-MAILED
- 13 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 26 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jul 2025 — USE AMENDMENT FILED
- 26 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 2 GRANTED
- 07 May 2025 — SOU EXTENSION 2 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2024 — SOU EXTENSION 1 GRANTED
- 05 Nov 2024 — SOU EXTENSION 1 FILED
- 05 Nov 2024 — SOU TEAS EXTENSION RECEIVED